Regent Peak Wealth Advisors LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1803329
ATLANTA, GA
Position in VRTX
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$316,417
+$53,852 QoQ
Shares Held
637
+8.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,207
of 1,735 holders
Holding Since
Dec 2020
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Regent Peak Wealth Advisors LLC holds $421,817 across 2 Biotechnology names. VRTX ranks #1 (75.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
637 | $316,417 | |
| 2 | ATAI |
AtaiBeckley Inc.
|
20,000 | $105,400 |
All Filings in VRTX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $316,417 | 637 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $262,565 | 588 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $257,055 | 567 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $209,919 | 536 | Shares | Sole | 2025-10-16 | |
| 2025-03-31 | $277,801 | 573 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $223,901 | 556 | Shares | Sole | 2025-01-07 | |
| 2024-09-30 | $265,095 | 570 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $259,670 | 554 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $226,143 | 541 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $202,224 | 497 | Shares | Sole | 2024-01-23 | |
| 2020-12-31 | $126,205 | 534 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||